In conclusion, we have identified patients with NSCLC carrying the rs25487 (XRCC1), rs3218556 (XRCC2), and rs13181 (XPD) SNPs, which appear to contribute to the efficacy and toxicity of radiotherapy. The gene discussed is XRCC1; the disease is non-small cell lung carcinoma.